Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|December 6, 2017
Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT studyPhilip Home, Francoise Calvi-Gries, Lawrence Blonde, et al.Diabetes Care|November 26, 2014
Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantationAugustin M Brooks, Richard Oram, Philip Home, et al.Diabetes Technology & Therapeutics|September 24, 2013
Biphasic insulin aspart 30 in insulin-naive people with type 2 diabetes in non-western nations: results from a regional comparative multinational observational study (A(1)chieve)Siddharth Shah, Wenying Yang, Mohammad Imtiaz Hasan, et al.Diabetes/Metabolism Research and Reviews|August 31, 2002
Considerations on blood glucose management in Type 2 diabetes mellitusPhilip Home, Antonio Chacra, Juliana Chan, et al.Annals of the New York Academy of Sciences|December 8, 2006
Predicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up studyLatika Sibal, Huong Nai Law, Janice Gebbie, et al.Current Medical Research and Opinion|May 1, 2010
Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trialsVivian Fonseca, Jaime Davidson, Philip Home, et al.Diabetes Research and Clinical Practice|December 14, 2011
An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve studyPhilip Home, Nabil El Naggar, Mohammed Khamseh, et al.Diabetes Research and Clinical Practice|September 23, 2017
Insulin regimens and glycemic control in different parts of Europe over 4years after starting insulin in people with type 2 diabetes: Data from the CREDIT non-interventional studyLawrence Blonde, Michel Marre, Maya Vincent, et al.Journal of Diabetes Science and Technology|May 31, 2014
Impact of Biosimilar Insulins on Clinical Practice: Meeting ReportRichard O Dolinar, Steve Edelman, Lutz Heinemann, et al.Diabetes Technology & Therapeutics|January 23, 2018
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with DiabetesPhilip Home, Karl-Michael Derwahl, Monika Ziemen, et al.Pageof 5